Loading...
Loading...
Itegra LifeSciences Holdings Corporation
IART today announced that it has priced its previously announced underwritten public offering of 3,500,000 shares of its common stock at $40.00 per share. In connection with the offering, Integra has also granted the underwriters a 30-day option to purchase an additional 525,000 shares of common stock. The offering is expected to close on November 13, 2013, subject to customary closing conditions.
Integra intends to use the net proceeds from the offering, including any net proceeds received from an exercise of the underwriters' option to purchase additional shares, for general corporate purposes which may include reducing outstanding borrowings under Integra's senior credit facility and paying a portion of the purchase price for the proposed acquisition by Integra LifeSciences Corporation, Integra's wholly-owned subsidiary, of Confluent Surgical, Inc., including its DuraSeal™ product line.
The shares will be issued pursuant to an effective shelf registration statement on Form S-3. Before investing in the offering, interested parties should read the prospectus and related prospectus supplement for this offering and the other documents Integra has filed with the Securities and Exchange Commission.
Morgan Stanley, BofA Merrill Lynch, Wells Fargo Securities and RBC Capital Markets are
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in